Osaic Holdings
JNCE

Osaic Holdings’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Osaic Holdings’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,350
Closed -$4.35K – 7704
2023
Q1 		$4.35K Buy
2,350
+1,100
+88% +$1.36K ﹤0.01% 6397
2022
Q4 		$1.28K Buy
1,250
+1,150
+1,150% +$1.64K ﹤0.01% 6800
2022
Q3 		$0 Hold
100
– – ﹤0.01% 7665
2022
Q2 		$0 Sell
100
-32
-24% -$156 ﹤0.01% 7743
2022
Q1 		$1K Hold
132
– – ﹤0.01% 7167
2021
Q4 		$1K Buy
132
+32
+32% +$264 ﹤0.01% 7307
2021
Q3 		$1K Hold
100
– – ﹤0.01% 7127
2021
Q2 		$1K Hold
100
– – ﹤0.01% 6933
2021
Q1 		$1K Sell
100
-9,799
-99% -$107K ﹤0.01% 6733
2020
Q4 		$69K Buy
9,899
+2,945
+42% +$22.9K ﹤0.01% 4327
2020
Q3 		$49K Buy
6,954
+96
+1% +$595 ﹤0.01% 4322
2020
Q2 		$47K Buy
6,858
+2,178
+47% +$11.7K ﹤0.01% 4243
2020
Q1 		$23K Buy
+4,680
New +$26.9K ﹤0.01% 4550

Other funds holding JNCE

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Osaic Holdings's JNCE Position: Q2 2023 in Review

Osaic Holdings sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 2,350 shares — an estimated $4.35K sold.

Osaic Holdings first reported a position in JNCE in Q1 2020 and held it in 13 quarters. The position peaked at $69K in Q4 2020. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.

  • Osaic Holdings reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Osaic Holdings sold 2,350 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $4.35K.
  • Osaic Holdings first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
  • Osaic Holdings's Jounce Therapeutics, Inc. Common Stock position peaked at $69K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.